https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Ser/thr phosphatases: the new frontier for myeloid leukemia therapy? https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:15147 Wed 11 Apr 2018 09:27:11 AEST ]]> Activation of protein phosphatase 2A in FLT3+ acute myeloid leukemia cells enhances the cytotoxicity of FLT3 tyrosine kinase inhibitors https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:27776 Thu 28 Oct 2021 13:04:26 AEDT ]]> Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT⁺ cancers https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:11381 Sat 24 Mar 2018 08:11:51 AEDT ]]>